Jiangsu Hengrui Pharmaceuticals Co., Ltd.

  • Market Cap: Large Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE0000014W7
CNY
51.63
-2.47 (-4.57%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Net Sales
31,431.03
27,787.84
22,646.61
21,122.45
25,738.85
27,509.46
23,102.49
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
31,431.03
27,787.84
22,646.61
21,122.45
25,738.85
27,509.46
23,102.49
Raw Material Cost
4,757.08
4,205.63
3,930.58
3,749.47
4,002.28
3,544.95
3,185.14
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
15.07
6.50
6.66
7.60
7.09
6.56
9.28
Selling and Distribution Expenses
11,837.05
10,784.31
9,863.55
9,642.77
12,177.82
12,847.14
10,743.01
Other Expenses
665.11
629.74
465.52
465.40
573.79
481.49
365.12
Total Expenditure (Excl Depreciation)
23,260.33
21,293.85
18,456.03
18,053.85
21,925.07
21,213.53
17,588.66
Operating Profit (PBDIT) excl Other Income
8170.700000000001
6494
4190.6
3068.6000000000004
3813.8
6295.900000000001
5513.8
Other Income
627.68
688.81
767.44
1,078.23
679.32
628.71
549.41
Operating Profit (PBDIT)
9,588.73
7,959.96
5,668.66
4,736.73
4,984.84
7,360.76
6,672.45
Interest
15.07
6.50
6.66
7.60
7.09
6.56
9.28
Exceptional Items
173.57
108.63
-128.26
-53.50
36.23
16.50
37.53
Gross Profit (PBDT)
26,673.95
23,582.22
18,716.03
17,372.99
21,736.58
23,964.52
19,917.35
Depreciation
942.47
870.82
793.94
644.15
540.73
475.22
644.94
Profit Before Tax
8,804.77
7,191.27
4,739.81
4,031.49
4,473.25
6,895.48
6,055.76
Tax
990.62
832.70
389.29
153.42
-17.72
586.59
729.31
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
7,711.05
6,336.53
4,302.44
3,906.30
4,530.22
6,328.38
5,328.03
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
7,711.05
6,336.53
4,302.44
3,906.30
4,530.22
6,328.38
5,328.03
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
5.95
0.47
-24.62
-91.23
-46.19
-19.49
-1.58
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
7,717.00
6,336.99
4,277.82
3,815.07
4,484.03
6,308.89
5,326.45
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
61,272.07
45,519.86
40,465.80
37,823.81
35,002.96
30,504.30
24,775.32
Earnings per share (EPS)
1.18
1.0
0.68
0.61
0.71
1.0
0.84
Diluted Earnings per share
1.18
1.0
0.68
0.61
0.71
1.0
0.84
Operating Profit Margin (Excl OI)
25.51%
23.03%
18.14%
14.27%
14.63%
22.74%
23.71%
Gross Profit Margin
31.01%
29.01%
24.44%
22.14%
19.48%
26.79%
29.0%
PAT Margin
24.53%
22.8%
19.0%
18.49%
17.6%
23.0%
23.06%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Dec 2025 is 13.11% vs 22.70% in Dec 2024

stock-summary

Consolidate Net Profit

YoY Growth in year ended Dec 2025 is 21.78% vs 48.14% in Dec 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Dec 2025 is 23.24% vs 48.36% in Dec 2024

stock-summary

Interest

YoY Growth in year ended Dec 2025 is 132.31% vs -2.99% in Dec 2024

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in year ended Dec 2025 has improved from Dec 2024

Compare Annual Results Of Jiangsu Hengrui Pharmaceuticals Co., Ltd. With
Markets Mojo
Figures in Million
Consolidate Annual Results
Markets Mojo
Markets Mojo
Change(CNY)
Change(%)
Net Sales
31,431.03
0
31,431.03
Other Operating Income
0.00
0.00
0.00
Total Operating income
31,431.03
0
31,431.03
Raw Material Cost
4,757.08
0
4,757.08
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
15.07
0
15.07
Selling and Distribution Expenses
11,837.05
0
11,837.05
Other Expenses
665.11
0.00
665.11
Total Expenditure (Excl Depreciation)
23,260.33
0
23,260.33
Operating Profit (PBDIT) excl Other Income
8,170.70
0.00
8,170.70
Other Income
627.68
0
627.68
Operating Profit (PBDIT)
9,588.73
0
9,588.73
Interest
15.07
0
15.07
Exceptional Items
173.57
0
173.57
Gross Profit (PBDT)
26,673.95
0
26,673.95
Depreciation
942.47
0
942.47
Profit Before Tax
8,804.77
0
8,804.77
Tax
990.62
0
990.62
Provisions and contingencies
0
0
0.00
Profit After Tax
7,711.05
0
7,711.05
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
7,711.05
0
7,711.05
Share in Profit of Associates
0
0
0.00
Minority Interest
5.95
0
5.95
Other related items
0.00
0.00
0.00
Consolidated Net Profit
7,717.00
0
7,717.00
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
61,272.07
0
61,272.07
Earnings per share (EPS)
1.18
0
1.18
Diluted Earnings per share
1.18
0
1.18
Operating Profit Margin (Excl OI)
25.51%
0%
0.00
25.51%
Gross Profit Margin
31.01%
0%
0.00
31.01%
PAT Margin
24.53%
0%
0.00
24.53%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 3,143.10 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is 13.11% vs 22.70% in Dec 2024

Annual - Consolidate Net Profit
Consolidate Net Profit 771.70 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is 21.78% vs 48.14% in Dec 2024

Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 896.10 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is 23.24% vs 48.36% in Dec 2024

Annual - Interest
Interest 1.51 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is 132.31% vs -2.99% in Dec 2024

Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 25.51%
in Dec 2025

Figures in %
stock-summary

YoY Growth in year ended Dec 2025 has improved from Dec 2024